Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002814346 | SCV003030755 | uncertain significance | Cobalamin C disease | 2022-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 201 of the MMACHC protein (p.Arg201His). This variant is present in population databases (rs200515707, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with MMACHC-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MMACHC protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002795888 | SCV003741553 | uncertain significance | Inborn genetic diseases | 2021-08-30 | criteria provided, single submitter | clinical testing | The c.602G>A (p.R201H) alteration is located in exon 4 (coding exon 4) of the MMACHC gene. This alteration results from a G to A substitution at nucleotide position 602, causing the arginine (R) at amino acid position 201 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV002814346 | SCV004178204 | uncertain significance | Cobalamin C disease | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003481334 | SCV004227834 | uncertain significance | not provided | 2023-01-03 | criteria provided, single submitter | clinical testing |